Evaluation of inadequate, indeterminate, false-negative and false-positive cases in cytological examination for breast cancer according to histological type

Diagnostic Pathology

Hirohisa Yano²  Masayoshi Kage³  Jiro Watanabe⁴  Koichi Higaki⁴  Mariko Nagao⁴  Hidejiro Higuchi⁴  Sonoe Ito⁴  Yasuhide Nonaka⁴  Kuniko Mibuchi⁴  Toshiro Yokoyama⁴  Takashi Koshikawa¹  Shin-ichi Tsuchiya⁶  Rin Yamaguchi⁵ 

[1] Department of Pathology, Aichi Prefectural University, School of Nursing & Health, Aichi, Japan;Department of Pathology, Kurume University School of Medicine, Kurume, Japan;Department of Diagnostic Pathology, Kurume University Hospital, Kurume, Japan;Working Team for the Accuracy of Breast Cytology, Southern Fukuoka Prefecture, Fukuoka, Japan;Department of Pathology, Kurume University School of Medicine, 67 Asahi-machi, Kurume, Fukuoka, 830-0011, Japan;Department of Diagnostic Pathology, Nippon Medical School Hospital, Tokyo, Japan

关键词: Inadequate;    Indeterminate;    False-positive;    False-negative;    Breast cytology;   

Others  :  808094
DOI  :  10.1186/1746-1596-7-53

 received in 2012-03-23, accepted in 2012-05-01,  发布年份 2012

【 摘 要 】

Background

We previously investigated the current status of breast cytology cancer screening at seven institutes in our area of southern Fukuoka Prefecture, and found some differences in diagnostic accuracy among the institutions. In the present study, we evaluated the cases involved and noted possible reasons for their original cytological classification as inadequate, indeterminate, false-negative and false-positive according to histological type.

Methods

We evaluated the histological findings in 5693 individuals who underwent cytological examination for breast cancer (including inadequate, indeterminate, false-negative and false-positive cases), to determine the most common histological types and/or features in these settings and the usefulness/limitations of cytological examination for the diagnosis of breast cancer.

Results

Among 1152 cytologically inadequate cases, histology revealed that 75/173 (43.6%) cases were benign, including mastopathy (fibrocystic disease) in 38.6%, fibroadenoma in 24.0% and papilloma in 5.3%. Ninety-five of 173 (54.9%) cases were histologically malignant, with scirrhous growing type, invasive ductal carcinoma (SIDC) being significantly more frequent (49.5%) than papillotubular growing type (Papi-tub) (P < 0.0001), solid-tubular growing type (P = 0.0001) and ductal carcinoma in situ (DCIS) (P = 0.0001). Among 458 indeterminate cases, 54/139 (38.8%) were histologically benign (mastopathy, 30.0%; fibroadenoma, 27.8%; papilloma, 26.0%) and 73/139 (52.5%) were malignant, with SIDC being the most frequent malignant tumor (37.0%). Among 52 false-negative cases, SIDC was significantly more frequent (42.3%) than DCIS (P = 0.0049) and Papi-tub (P = 0.001). There were three false-positive cases, with one each of fibroadenoma, epidermal cyst and papilloma.

Conclusions

The inadequate, indeterminate, false-negative and false-positive cases showed similar histological types, notably SIDC for malignant tumors, and mastopathy, fibroadenoma and papilloma for benign cases. We need to pay particular attention to the collection and assessment of aspirates for these histological types of breast disease. In particular, several inadequate, indeterminate and false-negative cases with samples collected by aspiration were diagnosed as SIDC. These findings should encourage the use of needle biopsy rather than aspiration when this histological type is identified on imaging. Namely, good communication between clinicians and pathological staff, and triple assessment (i.e., clinical, pathological and radiological assessment), are important for accurate diagnosis of aspiration samples.

Virtual slides

The virtual slide(s) for this article can be found here:http://www.diagnosticpathology.diagnomx.eu/vs/7349809170055423 webcite

【 授权许可】

   
2012 Yamaguchi et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

Figure 7.

【 参考文献 】

• [1]Kocjan G, Bourgain C, Fassina A, Hagmar B, Herbert A, Kapila K, Kardum-Skelin I, Kloboves-Prevodnik V, Krishnamurthy S, Koutselini H, Majak B, Olszewski W, Onal B, Pohar-Marinsek Z, Shabalova I, Smith J, Tani E, Vielh P, Wiener H, Schenck U, Schmitt F: The role of breast FNAC in diagnosis and clinical management: a survey of current practice. Cytopathology 2008, 19(5):271-278. Review.
• [2]Kocjan G: Fine needle aspiration cytology. Cytopathology 2003, 14(6):307-308. Review.
• [3]Levine T: Breast cytology–is there still a role? Cytopathology 2004, 15(6):293-296.
• [4]Sakamoto G, Inaji H, Akiyama F, Haga S, Hiraoka M, Inai K, Iwase T, Kobayashi S, Sano M, Sato T, Sonoo H, Tsuchiya S, Watanabe T: General rules for clinical and pathological recording of breast cancer. Breast Cancer 2005, 12(Suppl):S10-S11.
• [5]Yamaguchi R, Tsuchiya S, Koshikawa T, Yokoyama T, Mibuchi K, Nonaka Y, Ito S, Higuchi H, Nagao M, Watanabe J, Higaki K, Kage M, Yano H: Comparison of the accuracy of breast cytological diagnosis at seven institutions in southern Fukuoka Prefecture, Japan. Jpn J Clin Oncol 2012, 42(1):21-28.
• [6]Singh N, Wells A: Assessment of accuracy in breast cytology. Cytopathology 2001, 12(4):211-218.
• [7]Wells CA, Ellis IO, Zakhour HD, Wilson AR: Guidelines for cytology procedures and reporting on fine needle aspirates of the breast. Cytology Subgroup of the National Coordinating Committee for Breast Cancer Screening Pathology. Cytopathology 1994, 5(5):316-334.
• [8]Zarbo RJ, Howanitz PJ, Bachner P: Interinstitutional comparison of performance in breast fine-needle aspiration cytology. A Q-probe quality indicator study. Arch Pathol Lab Med 1991, 115(8):743-750.
• [9]Zagorianakou P, Fiaccavento S, Zagorianakou N, Makrydimas G, Stefanou D, Agnantis NJ: FNAC: its role, limitations and perspective in the preoperative diagnosis of breast cancer. Eur J Gynaecol Oncol 2005, 26(2):143-149. Review.
• [10]Tavassoli FA, Devilli P (Eds): WHO classification of tumours In Breast and Female Genital Organs. World Health Organization Classfication of Tumours. Lyon, France: IARC Press; 2003:19-21.
• [11]Park IA, Ham EK: Fine needle aspiration cytology of palpable breast lesions. Histologic subtype in false negative cases. Acta Cytol 1997, 41(4):1131-1138.
• [12]Ogawa Y, Kato Y, Nakata B, Yoshikawa K, Kawabata S, Wakasa K, Sakurai M, Sowa M: Diagnostic potential and pitfalls of ultrasound-guided fine-needle aspiration cytology for breast lesions. Surg Today 1998, 28(2):167-172.
• [13]Ishikawa T, Hamaguchi Y, Tanabe M, Momiyama N, Chishima T, Nakatani Y, Nozawa A, Sasaki T, Kitamura H, Shimada H: False-positive and false-negative cases of fine-needle aspiration cytology for palpable breast lesions. Breast Cancer 2007, 14(4):388-392.
• [14]Kuroda H, Takeuchi I, Ohnishi K, Sakamoto G, Akiyama F, Toyozumi Y, Momose S, Tamaru J, Itoyama S: Clinical and pathologic features of fibroadenoma of the mastopathic type. Surg Today 2006, 36(7):590-595.
• [15]Yamaguchi R, Futamata Y, Yoshimura F, Murakami N, Koufuji K, Kutami R, Kojima K, Ohki S, Kurata S, Kaida H, Ishibashi M, Yano H: Mastopathic-type fibroadenoma and ductal adenoma of the breast with false-positive fluorodeoxyglucose positron emission tomography. Jpn J Radiol 2009, 27(7):280-284.
• [16]Mori I, Han B, Wang X, Taniguchi E, Nakamura M, Nakamura Y, Bai Y, Kakudo K: Mastopathic fibroadenoma of the breast: a pitfall of aspiration cytology. Cytopathology 2006, 17(5):233-238.
• [17]Yamaguchi R, Tanaka M, Mizushima Y, Hirai Y, Yamaguchi M, Kaneko Y, Terasaki H, Yokoyama T, Nonaka Y, Yano H: Myxomatous fibroadenoma of the breast: correlation with clinicopathological and radiological features. Hum Pathol 2011, 42(3):419-423.
• [18]Yamaguchi R, Tanaka M, Yokoyama T, Nonaka Y, Mizushima Y, Kawahara A, Yoshida T, Ito T, Yamaguchi M, Kage M, Yano H: Cytological features of myxomatous fibroadenoma of the breast. Diagn Cytopathol 2012, 40(4):316-320.
• [19]Tse GM, Tan PH: Diagnosing breast lesions by fine needle aspiration cytology or core biopsy: which is better? Breast Cancer Res Treat 2010, 123(1):1-8.